Wall Street extends rally to second day on trade optimism

Amazon.com Inc and Microsoft Corp fuelled a second straight session of gains on Wall Street on Monday, with the resumption of U.S.-China trade talks helping ease concerns that have pummelled the market in recent months.

Fed’s Bostic sees one U.S. interest rate hike this year

The Federal Reserve may only need to raise interest rates once in 2019, Atlanta Fed President Raphael Bostic said on Monday, focusing on business executives’ nervousness about the economy and a global slowdown as factors that may hold the U.S. central bank back.

World Bank’s Kim to resign effective Feb 1, work on infrastructure

World Bank Group President Jim Yong Kim, who was at odds with the Trump administration’s policies on climate change, will resign effective Feb. 1, more than three years ahead of his term’s expiration, the multilateral lender said on Monday.

U.S. top court rejects Amgen over cholesterol medication patent fight

Amgen Inc on Monday lost its bid at the U.S. Supreme Court to overturn a ruling that kept the Regeneron Pharmaceuticals Inc and Sanofi SA cholesterol-lowering drug Praluent on the market, but the patent dispute among the rival drugmakers will continue in another trial.

Activist Starboard seeks Dollar Tree board changes, disposal

Activist hedge fund Starboard Value LP on Monday called on Dollar Tree Inc to sell its underperforming Family Dollar business and proposed replacing a majority of the board after revealing a stake in the U.S. discount retailer.

U.S. top court declines to take up Fiat Chrysler hacking case

The U.S. Supreme Court on Monday declined to hear Fiat Chrysler’s appeal in a class action lawsuit over allegations that its Jeeps and other trucks are vulnerable to hacking, one of the first legal cases involving automotive cyber security risks.

U.S. Supreme Court could side with Merck over Fosamax lawsuits

U.S. Supreme Court justices on Monday appeared sympathetic to Merck & Co in its bid to fend off hundreds of lawsuits accusing the company of failing to adequately warn patients of the risks of thigh bone fractures associated with its osteoporosis drug Fosamax.